Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro. (Q34550420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Leong CT

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Tay SK

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Huynh H

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

24 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

870-880

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

Cloning and uterus/oviduct-specific expression of a novel estrogen-regulated gene (ERG1)

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

siRNA-based approaches in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Disruption of epithelial cell-matrix interactions induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Induction of UO-44 gene expression by tamoxifen in the rat uterus and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Protection from pancreatitis by the zymogen granule membrane protein integral membrane-associated protein-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Molecular cloning, characterization and isolation of novel spliced variants of the human ortholog of a rat estrogen-regulated membrane-associated protein, UO-44

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Primary ovarian cancer chemotherapy: current standards of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

siRNA therapeutics: big potential from small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

The genesis of RNA interference, its potential clinical applications, and implications in gynecologic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Targeted mRNA degradation by double-stranded RNA in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

A cDNA cloned from pregnant mouse uterus exhibits temporo-spatial expression and predicts a novel protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

inferred from DOI database lookup

7 January 2021

based on heuristic

A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209836

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1209836

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862170%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 December 2019

1023425612

0 references

Fatcat ID

release_nm7yv2xs3vc3vns5jpv346v27m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nm7yv2xs3vc3vns5jpv346v27m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference